Invivyd
Keith White is currently the Head of Drug Substance Manufacturing at Invivyd since April 2021. Prior to this role, Keith worked at Genentech for over 17 years, starting as a Process Engineer and eventually transitioning to the role of Principal Engineer. Keith was a key member of the Genentech Vacaville Site Technology Transfer Team, where Keith played a crucial role in transferring technical processes for drug substance manufacturing. Before their tenure at Genentech, Keith worked at XOMA as a Process Engineer and eventually became a Manager. Keith holds a Bachelor of Science degree in Chemical Engineering and Biochemical Engineering from the University of California, Davis.
This person is not in any offices
Invivyd
1 followers
Invivyd is a clinical-stage a biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses.